Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26
MDxHealth SA (NASDAQ: MDXH) has announced it will release its Q4 and full year 2024 financial results after market close on February 26, 2025. The company will host a conference call and webcast at 4:30pm ET / 22:30 CET on the same day.
The conference call will feature CEO Michael K. McGarrity and CFO Ron Kalfus, with dial-in numbers provided for the United States, Belgium, The Netherlands, and the United Kingdom. A webcast replay will be available on the company's website following the live call.
MDxHealth SA (NASDAQ: MDXH) ha annunciato che rilascerà i suoi risultati finanziari del Q4 e dell'intero anno 2024 dopo la chiusura del mercato il 26 febbraio 2025. L'azienda ospiterà una conferenza telefonica e un webcast alle 16:30 ET / 22:30 CET lo stesso giorno.
La conferenza telefonica vedrà la partecipazione del CEO Michael K. McGarrity e del CFO Ron Kalfus, con numeri di accesso forniti per gli Stati Uniti, il Belgio, i Paesi Bassi e il Regno Unito. Una registrazione del webcast sarà disponibile sul sito web dell'azienda dopo la chiamata dal vivo.
MDxHealth SA (NASDAQ: MDXH) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 después del cierre del mercado el 26 de febrero de 2025. La compañía llevará a cabo una conferencia telefónica y un webcast a las 4:30 p.m. ET / 22:30 CET el mismo día.
La conferencia contará con la participación del CEO Michael K. McGarrity y del CFO Ron Kalfus, con números de acceso proporcionados para Estados Unidos, Bélgica, Países Bajos y Reino Unido. Una repetición del webcast estará disponible en el sitio web de la empresa después de la llamada en vivo.
MDxHealth SA (NASDAQ: MDXH)는 2024년 4분기 및 연간 재무 결과를 2025년 2월 26일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 4시 30분 ET / 오후 10시 30분 CET에 전화 회의 및 웹캐스트를 개최할 예정입니다.
전화 회의에는 CEO Michael K. McGarrity와 CFO Ron Kalfus가 참석하며, 미국, 벨기에, 네덜란드 및 영국을 위한 전화 접속 번호가 제공됩니다. 라이브 통화 후 회사 웹사이트에서 웹캐스트 재생이 제공될 예정입니다.
MDxHealth SA (NASDAQ: MDXH) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 après la clôture du marché le 26 février 2025. L'entreprise organisera une conférence téléphonique et un webcast à 16h30 ET / 22h30 CET le même jour.
La conférence téléphonique mettra en vedette le PDG Michael K. McGarrity et le CFO Ron Kalfus, avec des numéros d'appel fournis pour les États-Unis, la Belgique, les Pays-Bas et le Royaume-Uni. Une rediffusion du webcast sera disponible sur le site Web de l'entreprise après l'appel en direct.
MDxHealth SA (NASDAQ: MDXH) hat angekündigt, dass es seine Finanzergebnisse für das 4. Quartal und das gesamte Jahr 2024 nach Marktende am 26. Februar 2025 veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr ET / 22:30 Uhr CET eine Telefonkonferenz und einen Webcast veranstalten.
Die Telefonkonferenz wird von CEO Michael K. McGarrity und CFO Ron Kalfus geleitet, wobei Einwahlnummern für die USA, Belgien, die Niederlande und das Vereinigte Königreich bereitgestellt werden. Eine Aufzeichnung des Webcasts wird nach der Live-Anruf auf der Website des Unternehmens verfügbar sein.
- None.
- None.
Company to Host Conference Call with Live Q&A, February 26, 2025, at 4:30pm ET / 22:30 CET
IRVINE, CA, and HERSTAL, BELGIUM – February 12, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2024, after market close on Wednesday, February 26, 2025.
| Title: | Mdxhealth Presents Fourth Quarter and Full Year 2024 Financial Results and Corporate Update Conference Call and Webcast |
| Speakers: | Michael K. McGarrity, Chief Executive Officer Ron Kalfus, Chief Financial Officer |
| Date: | February 26, 2025 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call Dial-in Details: | United States: 1-844-825-9789 Belgium: 0800 38 961 The Netherlands: 0800 94 94 506 United Kingdom: 0808 238 9064 |
| Conference ID: | 10196702 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1706814&tp_key=e01537d9e2 |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About Mdxhealth
Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
| MDxHealth info@mdxhealth.com | |
| LifeSci Advisors (IR & PR) US: +1 949 271 9223 ir@mdxhealth.com |
FAQ
When will MDxHealth (MDXH) release its Q4 and full year 2024 financial results?
What time is MDxHealth's (MDXH) Q4 2024 earnings call?
Who will be presenting at MDxHealth's (MDXH) Q4 2024 earnings call?
Will there be a replay available for MDxHealth's (MDXH) Q4 2024 earnings call?
